YM BioSciences and Cytopia propose to merge
This article was originally published in Scrip
Executive Summary
Cancer-focused biotechnology companies YM BioSciences of Canada and Australian firm Cytopia are proposing to merge in a deal valued at around Can$10 million (US$9.5 million).